s6y

Altamira Therapeutics Ltd.

Ticker
CYTOF
CIK
1601936
Industry
Pharmaceutical Preparations
Formerly
Auris Medical Holding Ltd., Auris Medical Holding AG, Auris Medical AG

Financials 1

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2022

News 2

  1. 8-K12G3 Notification that a class of securities of successor issuer is deemed to be registered pursuant to Section 12(g)
  2. 8-K12G3 Notification that a class of securities of successor issuer is deemed to be registered pursuant to Section 12(g)

Ownership 51

  1. SC 13G Major Shareholders
  2. SC 13D/A Major Shareholders
  3. SC 13D/A Major Shareholders
  4. SC 13D/A Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D/A Major Shareholders
  7. SC 13D/A Major Shareholders
  8. SC 13G/A Major Shareholders
  9. SC 13D/A Major Shareholders
  10. SC 13D/A Major Shareholders

All 51 ownership filings

Prospectus 96

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. RW Registration Withdrawal Request

All 96 prospectus filings

Other 368

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. SCHEDULE 13G/A
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. SCHEDULE 13D/A
  8. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 368 other filings